Retraction
Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy
Paper Information
Record ID:
59185
Author(s):
Publication Date:
September 07, 2021
Retraction Date:
December 13, 2023
(1.9 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- The Affiliated Nanhua Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
- The Affiliated Nanhua Hospital, Department of Recovery from Anesthesia, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
- The Affiliated Nanhua Hospital, Department of Nursing Teaching and Research, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (6)
6
Total Citations1
Post-Retraction(16.7%)
4
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
444
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke Within 4.5 h: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Muhammad Waseem, Zain Ul Abideen, Aiman Waheed et al. (13 authors)
Brain and Behavior
Open Access
Published: Mar 2025
444 days after retraction
Reperfusion strategies in patients with ST-segment elevation myocardial infarction during hospitalization in China: Findings from the Improving Care for Cardiovascular disease in China (CCC)-Acute Cronary Synrome project
Jun Wang, Z. ZHANG, Jing Li et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2023
2 days before retraction
In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
Yilin Yang, Boram Gu, Xiao Yun Xu
Pharmaceutics
Open Access
Published: Feb 2023
6 citations
6 citations
288 days before retraction
Retracted: Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
346 days before retraction
Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials
Gang Fan, Xiang-Ge Wu, Wen-Ping Jiao et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Nov 2022
6 citations
6 citations
378 days before retraction
Quick Stats
Total Citations:
9
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025